Evaluation of whole-body cancer screening using 18F-2-deoxy-2-fluoro-d-glucose positron emission tomography: a preliminary report View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2008-06

AUTHORS

Takashi Terauchi, Takeshi Murano, Hiromitsu Daisaki, Daisuke Kanou, Hiroko Shoda, Ryutaro Kakinuma, Chisato Hamashima, Noriyuki Moriyama, Tadao Kakizoe

ABSTRACT

OBJECTIVE: (18)F-2-deoxy-2-fluoro-D-glucose positron emission tomography (FDG-PET) is a promising screening modality targeting whole body. However, the validity of PET cancer screening remains to be assessed. Even the screening accuracy for whole-body screening using FDG-PET has not been evaluated. In this study, we investigated the screening accuracy of PET cancer screening. METHODS: A total of 2911 asymptomatic participants (1629 men and 1282 women, mean age 59.79 years) underwent both FDG-PET and other thorough examinations for multiple organs (gastrofiberscopy, total colonofiberscopy or barium enema, low-dose thin section computed tomography and sputum cytology, abdominal ultrasonography, an assay of prostate-specific antigen, mammography, mammary ultrasonography, Pap smear for the uterine cervix, and magnetic resonance imaging for the endometrium and ovaries) between February 2004 and January 2005, and followed sufficiently. The detection rate, sensitivity, specificity, and positive predictive value of FDG-PET were calculated using cancer data obtained from all examinations along with a 1 year follow-up. RESULTS: From among 2911 participants FDG-PET found 28 cancers, 129 cancers were PET negative. PET-positive cancers comprised seven colorectal cancers, four lung cancers, four thyroid cancers, three breast cancers, two gastric cancers, two prostate cancers, two small intestinal sarcomas (gastrointestinal stromal tumors), one malignant lymphoma, one head and neck malignancy (nasopharyngeal carcinoid tumor), one thymoma, and one hepatocellular carcinoma. PET-negative cancers included 22 gastric cancers and 20 prostate cancers that were essentially difficult to detect using FDG-PET. The overall detection rate, sensitivity, specificity, and positive predictive value were estimated to be 0.96%, 17.83%, 95.15%, and 11.20%, respectively. CONCLUSIONS: FDG-PET can detect a variety of cancers at an early stage as part of a whole-body screening modality. The detection rate of PET cancer screening was higher than that of other screening modalities, which had already shown evidence of efficacy. However, the sensitivity of PET cancer screening was lower than that of other thorough examinations performed at our institute. FDG-PET has some limitations, and cancer screening using only FDG-PET is likely to miss some cancers. More... »

PAGES

379-385

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s12149-008-0130-7

DOI

http://dx.doi.org/10.1007/s12149-008-0130-7

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1018700718

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/18600415


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Fluorodeoxyglucose F18", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mass Screening", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pilot Projects", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Radionuclide Imaging", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Radiopharmaceuticals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Reproducibility of Results", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sensitivity and Specificity", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Whole Body Imaging", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "National Cancer Centre", 
          "id": "https://www.grid.ac/institutes/grid.272242.3", 
          "name": [
            "Screening Technology and Development Division, Research Center for Cancer Prevention and Screening, National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, 104-0045, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Terauchi", 
        "givenName": "Takashi", 
        "id": "sg:person.0766725261.48", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0766725261.48"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "National Cancer Centre", 
          "id": "https://www.grid.ac/institutes/grid.272242.3", 
          "name": [
            "Screening Technology and Development Division, Research Center for Cancer Prevention and Screening, National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, 104-0045, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Murano", 
        "givenName": "Takeshi", 
        "id": "sg:person.01215532117.70", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01215532117.70"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "National Cancer Centre", 
          "id": "https://www.grid.ac/institutes/grid.272242.3", 
          "name": [
            "Screening Technology and Development Division, Research Center for Cancer Prevention and Screening, National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, 104-0045, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Daisaki", 
        "givenName": "Hiromitsu", 
        "id": "sg:person.0704464201.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0704464201.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "National Cancer Centre", 
          "id": "https://www.grid.ac/institutes/grid.272242.3", 
          "name": [
            "Screening Technology and Development Division, Research Center for Cancer Prevention and Screening, National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, 104-0045, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kanou", 
        "givenName": "Daisuke", 
        "id": "sg:person.0645165315.21", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0645165315.21"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "National Cancer Centre", 
          "id": "https://www.grid.ac/institutes/grid.272242.3", 
          "name": [
            "Screening Technology and Development Division, Research Center for Cancer Prevention and Screening, National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, 104-0045, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shoda", 
        "givenName": "Hiroko", 
        "id": "sg:person.0713300515.45", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0713300515.45"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "National Cancer Centre", 
          "id": "https://www.grid.ac/institutes/grid.272242.3", 
          "name": [
            "Screening Technology and Development Division, Research Center for Cancer Prevention and Screening, National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, 104-0045, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kakinuma", 
        "givenName": "Ryutaro", 
        "id": "sg:person.010057331517.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010057331517.03"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "National Cancer Centre", 
          "id": "https://www.grid.ac/institutes/grid.272242.3", 
          "name": [
            "Screening Assessment and Management Division, Research Center for Cancer Prevention and Screening, National Cancer Center, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hamashima", 
        "givenName": "Chisato", 
        "id": "sg:person.01027527115.88", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01027527115.88"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "National Cancer Centre", 
          "id": "https://www.grid.ac/institutes/grid.272242.3", 
          "name": [
            "Research Center for Cancer Prevention and Screening, National Cancer Center, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Moriyama", 
        "givenName": "Noriyuki", 
        "id": "sg:person.01062144612.81", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01062144612.81"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "National Cancer Centre", 
          "id": "https://www.grid.ac/institutes/grid.272242.3", 
          "name": [
            "National Cancer Center, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kakizoe", 
        "givenName": "Tadao", 
        "id": "sg:person.01337610735.59", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01337610735.59"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1002/(sici)1097-0142(19970215)79:4<695::aid-cncr6>3.0.co;2-d", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002320901"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1054/bjoc.2000.1496", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008190941", 
          "https://doi.org/10.1054/bjoc.2000.1496"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf01249629", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016456637", 
          "https://doi.org/10.1007/bf01249629"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf03034001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018059579", 
          "https://doi.org/10.1007/bf03034001"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf03034001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018059579", 
          "https://doi.org/10.1007/bf03034001"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0959-8049(95)00421-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029421313"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12149-007-0061-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036979330", 
          "https://doi.org/10.1007/s12149-007-0061-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf03164996", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039404426", 
          "https://doi.org/10.1007/bf03164996"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf03164996", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039404426", 
          "https://doi.org/10.1007/bf03164996"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/(sici)1097-0142(19980601)82:11<2227::aid-cncr18>3.0.co;2-w", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039814517"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0749-3797(01)00261-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041656773"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1046/j.1442-2042.2002.00416.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043008165"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0001-2998(96)80006-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046867727"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jama.285.7.914", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047716064"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf02984601", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050431834", 
          "https://doi.org/10.1007/bf02984601"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf02984601", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050431834", 
          "https://doi.org/10.1007/bf02984601"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jjco/hyl022", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052475020"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1055/s-2000-9875", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1057405567"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1210/jc.2003-030465", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064286866"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074508177", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1077689341", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082413673", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1083278017", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2008-06", 
    "datePublishedReg": "2008-06-01", 
    "description": "OBJECTIVE: (18)F-2-deoxy-2-fluoro-D-glucose positron emission tomography (FDG-PET) is a promising screening modality targeting whole body. However, the validity of PET cancer screening remains to be assessed. Even the screening accuracy for whole-body screening using FDG-PET has not been evaluated. In this study, we investigated the screening accuracy of PET cancer screening.\nMETHODS: A total of 2911 asymptomatic participants (1629 men and 1282 women, mean age 59.79 years) underwent both FDG-PET and other thorough examinations for multiple organs (gastrofiberscopy, total colonofiberscopy or barium enema, low-dose thin section computed tomography and sputum cytology, abdominal ultrasonography, an assay of prostate-specific antigen, mammography, mammary ultrasonography, Pap smear for the uterine cervix, and magnetic resonance imaging for the endometrium and ovaries) between February 2004 and January 2005, and followed sufficiently. The detection rate, sensitivity, specificity, and positive predictive value of FDG-PET were calculated using cancer data obtained from all examinations along with a 1 year follow-up.\nRESULTS: From among 2911 participants FDG-PET found 28 cancers, 129 cancers were PET negative. PET-positive cancers comprised seven colorectal cancers, four lung cancers, four thyroid cancers, three breast cancers, two gastric cancers, two prostate cancers, two small intestinal sarcomas (gastrointestinal stromal tumors), one malignant lymphoma, one head and neck malignancy (nasopharyngeal carcinoid tumor), one thymoma, and one hepatocellular carcinoma. PET-negative cancers included 22 gastric cancers and 20 prostate cancers that were essentially difficult to detect using FDG-PET. The overall detection rate, sensitivity, specificity, and positive predictive value were estimated to be 0.96%, 17.83%, 95.15%, and 11.20%, respectively.\nCONCLUSIONS: FDG-PET can detect a variety of cancers at an early stage as part of a whole-body screening modality. The detection rate of PET cancer screening was higher than that of other screening modalities, which had already shown evidence of efficacy. However, the sensitivity of PET cancer screening was lower than that of other thorough examinations performed at our institute. FDG-PET has some limitations, and cancer screening using only FDG-PET is likely to miss some cancers.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s12149-008-0130-7", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1099601", 
        "issn": [
          "0914-7187", 
          "1864-6433"
        ], 
        "name": "Annals of Nuclear Medicine", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "5", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "22"
      }
    ], 
    "name": "Evaluation of whole-body cancer screening using 18F-2-deoxy-2-fluoro-d-glucose positron emission tomography: a preliminary report", 
    "pagination": "379-385", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "591a2217a2980dae0ae8de93a899b328fc96c3d3723d8c66e97a17f9c15b6945"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "18600415"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8913398"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s12149-008-0130-7"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1018700718"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s12149-008-0130-7", 
      "https://app.dimensions.ai/details/publication/pub.1018700718"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T21:39", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8687_00000521.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007%2Fs12149-008-0130-7"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s12149-008-0130-7'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s12149-008-0130-7'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s12149-008-0130-7'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s12149-008-0130-7'


 

This table displays all metadata directly associated to this object as RDF triples.

242 TRIPLES      21 PREDICATES      62 URIs      34 LITERALS      22 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s12149-008-0130-7 schema:about N0224750797dc4b23a6a324f175f71b15
2 N167e682d20f54b9eb7e44a8062ca1182
3 N1d3cea0207fa4bf0bfdc3acab5c4807b
4 N3f2d1b3cf1bd41f085ffca4e550b9f44
5 N502ea202bfe144e6b80e56a89ae01859
6 N52ff3c9a000e4a5f8bbf3903ab703096
7 N786e83981d2d4192aead2bc742a88d15
8 N7b9795b3ceed4ffeae087d0af3002da7
9 N857b4fedd5cd4229917ce81eb3182154
10 Nb0594f80a7344418ba324a685817171d
11 Nc9c7e3347b2a414faa004ca2b82f1e3d
12 Nce6e2b9ec4b4464cbeeed5bf4f28d3b4
13 Nec24226232604d928f698a48fe5cb896
14 anzsrc-for:11
15 anzsrc-for:1112
16 schema:author N9ac5ff35052e4a7bb607d14714a81ab2
17 schema:citation sg:pub.10.1007/bf01249629
18 sg:pub.10.1007/bf02984601
19 sg:pub.10.1007/bf03034001
20 sg:pub.10.1007/bf03164996
21 sg:pub.10.1007/s12149-007-0061-8
22 sg:pub.10.1054/bjoc.2000.1496
23 https://app.dimensions.ai/details/publication/pub.1074508177
24 https://app.dimensions.ai/details/publication/pub.1077689341
25 https://app.dimensions.ai/details/publication/pub.1082413673
26 https://app.dimensions.ai/details/publication/pub.1083278017
27 https://doi.org/10.1001/jama.285.7.914
28 https://doi.org/10.1002/(sici)1097-0142(19970215)79:4<695::aid-cncr6>3.0.co;2-d
29 https://doi.org/10.1002/(sici)1097-0142(19980601)82:11<2227::aid-cncr18>3.0.co;2-w
30 https://doi.org/10.1016/0959-8049(95)00421-1
31 https://doi.org/10.1016/s0001-2998(96)80006-7
32 https://doi.org/10.1016/s0749-3797(01)00261-6
33 https://doi.org/10.1046/j.1442-2042.2002.00416.x
34 https://doi.org/10.1055/s-2000-9875
35 https://doi.org/10.1093/jjco/hyl022
36 https://doi.org/10.1210/jc.2003-030465
37 schema:datePublished 2008-06
38 schema:datePublishedReg 2008-06-01
39 schema:description OBJECTIVE: (18)F-2-deoxy-2-fluoro-D-glucose positron emission tomography (FDG-PET) is a promising screening modality targeting whole body. However, the validity of PET cancer screening remains to be assessed. Even the screening accuracy for whole-body screening using FDG-PET has not been evaluated. In this study, we investigated the screening accuracy of PET cancer screening. METHODS: A total of 2911 asymptomatic participants (1629 men and 1282 women, mean age 59.79 years) underwent both FDG-PET and other thorough examinations for multiple organs (gastrofiberscopy, total colonofiberscopy or barium enema, low-dose thin section computed tomography and sputum cytology, abdominal ultrasonography, an assay of prostate-specific antigen, mammography, mammary ultrasonography, Pap smear for the uterine cervix, and magnetic resonance imaging for the endometrium and ovaries) between February 2004 and January 2005, and followed sufficiently. The detection rate, sensitivity, specificity, and positive predictive value of FDG-PET were calculated using cancer data obtained from all examinations along with a 1 year follow-up. RESULTS: From among 2911 participants FDG-PET found 28 cancers, 129 cancers were PET negative. PET-positive cancers comprised seven colorectal cancers, four lung cancers, four thyroid cancers, three breast cancers, two gastric cancers, two prostate cancers, two small intestinal sarcomas (gastrointestinal stromal tumors), one malignant lymphoma, one head and neck malignancy (nasopharyngeal carcinoid tumor), one thymoma, and one hepatocellular carcinoma. PET-negative cancers included 22 gastric cancers and 20 prostate cancers that were essentially difficult to detect using FDG-PET. The overall detection rate, sensitivity, specificity, and positive predictive value were estimated to be 0.96%, 17.83%, 95.15%, and 11.20%, respectively. CONCLUSIONS: FDG-PET can detect a variety of cancers at an early stage as part of a whole-body screening modality. The detection rate of PET cancer screening was higher than that of other screening modalities, which had already shown evidence of efficacy. However, the sensitivity of PET cancer screening was lower than that of other thorough examinations performed at our institute. FDG-PET has some limitations, and cancer screening using only FDG-PET is likely to miss some cancers.
40 schema:genre research_article
41 schema:inLanguage en
42 schema:isAccessibleForFree false
43 schema:isPartOf N3bebe9c534174ecfa40d89e48ba3261d
44 Ndf988551fa1c44bd91513a9dd8e4860b
45 sg:journal.1099601
46 schema:name Evaluation of whole-body cancer screening using 18F-2-deoxy-2-fluoro-d-glucose positron emission tomography: a preliminary report
47 schema:pagination 379-385
48 schema:productId N276b759affa143398416c12ee4d2916c
49 N6df074db36c74b01823c06546e61f66b
50 Nce726d08b4b84be19a8769e5dfaa5f25
51 Ne422b4d33f204a86b615f9eb3f9c3e43
52 Neb93da05d321402c9f2a6680bc2996cc
53 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018700718
54 https://doi.org/10.1007/s12149-008-0130-7
55 schema:sdDatePublished 2019-04-10T21:39
56 schema:sdLicense https://scigraph.springernature.com/explorer/license/
57 schema:sdPublisher N032b89a67ef24c9f841c0a583f320267
58 schema:url http://link.springer.com/10.1007%2Fs12149-008-0130-7
59 sgo:license sg:explorer/license/
60 sgo:sdDataset articles
61 rdf:type schema:ScholarlyArticle
62 N0224750797dc4b23a6a324f175f71b15 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
63 schema:name Reproducibility of Results
64 rdf:type schema:DefinedTerm
65 N032b89a67ef24c9f841c0a583f320267 schema:name Springer Nature - SN SciGraph project
66 rdf:type schema:Organization
67 N167e682d20f54b9eb7e44a8062ca1182 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
68 schema:name Radiopharmaceuticals
69 rdf:type schema:DefinedTerm
70 N1d3cea0207fa4bf0bfdc3acab5c4807b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
71 schema:name Male
72 rdf:type schema:DefinedTerm
73 N276b759affa143398416c12ee4d2916c schema:name dimensions_id
74 schema:value pub.1018700718
75 rdf:type schema:PropertyValue
76 N32f983189bd0402d8c456a8a5d196c72 rdf:first sg:person.0645165315.21
77 rdf:rest Nf2133121f7734c1fb2e667748e793279
78 N34d3b35ee6744410b022a92f2f39bcea rdf:first sg:person.01062144612.81
79 rdf:rest N8047d8099c914ad5ad30ef21811ed670
80 N3bebe9c534174ecfa40d89e48ba3261d schema:volumeNumber 22
81 rdf:type schema:PublicationVolume
82 N3f2d1b3cf1bd41f085ffca4e550b9f44 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
83 schema:name Humans
84 rdf:type schema:DefinedTerm
85 N502ea202bfe144e6b80e56a89ae01859 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
86 schema:name Fluorodeoxyglucose F18
87 rdf:type schema:DefinedTerm
88 N52ff3c9a000e4a5f8bbf3903ab703096 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
89 schema:name Mass Screening
90 rdf:type schema:DefinedTerm
91 N5ce4498d7a7c4bd2bf85d2b0f513ddf8 rdf:first sg:person.010057331517.03
92 rdf:rest Nd76dbb2b711d4db7874569fc4539cb4b
93 N6df074db36c74b01823c06546e61f66b schema:name nlm_unique_id
94 schema:value 8913398
95 rdf:type schema:PropertyValue
96 N786e83981d2d4192aead2bc742a88d15 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
97 schema:name Whole Body Imaging
98 rdf:type schema:DefinedTerm
99 N7b9795b3ceed4ffeae087d0af3002da7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
100 schema:name Female
101 rdf:type schema:DefinedTerm
102 N8047d8099c914ad5ad30ef21811ed670 rdf:first sg:person.01337610735.59
103 rdf:rest rdf:nil
104 N857b4fedd5cd4229917ce81eb3182154 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
105 schema:name Middle Aged
106 rdf:type schema:DefinedTerm
107 N9ac5ff35052e4a7bb607d14714a81ab2 rdf:first sg:person.0766725261.48
108 rdf:rest Nccf165e2c8234054a1af7ff2b41061f2
109 Nb0594f80a7344418ba324a685817171d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Neoplasms
111 rdf:type schema:DefinedTerm
112 Nc9c7e3347b2a414faa004ca2b82f1e3d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Pilot Projects
114 rdf:type schema:DefinedTerm
115 Nccf165e2c8234054a1af7ff2b41061f2 rdf:first sg:person.01215532117.70
116 rdf:rest Nf2c4cfe3de0d4bbb818149354cf76b2f
117 Nce6e2b9ec4b4464cbeeed5bf4f28d3b4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Sensitivity and Specificity
119 rdf:type schema:DefinedTerm
120 Nce726d08b4b84be19a8769e5dfaa5f25 schema:name pubmed_id
121 schema:value 18600415
122 rdf:type schema:PropertyValue
123 Nd76dbb2b711d4db7874569fc4539cb4b rdf:first sg:person.01027527115.88
124 rdf:rest N34d3b35ee6744410b022a92f2f39bcea
125 Ndf988551fa1c44bd91513a9dd8e4860b schema:issueNumber 5
126 rdf:type schema:PublicationIssue
127 Ne422b4d33f204a86b615f9eb3f9c3e43 schema:name doi
128 schema:value 10.1007/s12149-008-0130-7
129 rdf:type schema:PropertyValue
130 Neb93da05d321402c9f2a6680bc2996cc schema:name readcube_id
131 schema:value 591a2217a2980dae0ae8de93a899b328fc96c3d3723d8c66e97a17f9c15b6945
132 rdf:type schema:PropertyValue
133 Nec24226232604d928f698a48fe5cb896 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Radionuclide Imaging
135 rdf:type schema:DefinedTerm
136 Nf2133121f7734c1fb2e667748e793279 rdf:first sg:person.0713300515.45
137 rdf:rest N5ce4498d7a7c4bd2bf85d2b0f513ddf8
138 Nf2c4cfe3de0d4bbb818149354cf76b2f rdf:first sg:person.0704464201.36
139 rdf:rest N32f983189bd0402d8c456a8a5d196c72
140 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
141 schema:name Medical and Health Sciences
142 rdf:type schema:DefinedTerm
143 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
144 schema:name Oncology and Carcinogenesis
145 rdf:type schema:DefinedTerm
146 sg:journal.1099601 schema:issn 0914-7187
147 1864-6433
148 schema:name Annals of Nuclear Medicine
149 rdf:type schema:Periodical
150 sg:person.010057331517.03 schema:affiliation https://www.grid.ac/institutes/grid.272242.3
151 schema:familyName Kakinuma
152 schema:givenName Ryutaro
153 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010057331517.03
154 rdf:type schema:Person
155 sg:person.01027527115.88 schema:affiliation https://www.grid.ac/institutes/grid.272242.3
156 schema:familyName Hamashima
157 schema:givenName Chisato
158 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01027527115.88
159 rdf:type schema:Person
160 sg:person.01062144612.81 schema:affiliation https://www.grid.ac/institutes/grid.272242.3
161 schema:familyName Moriyama
162 schema:givenName Noriyuki
163 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01062144612.81
164 rdf:type schema:Person
165 sg:person.01215532117.70 schema:affiliation https://www.grid.ac/institutes/grid.272242.3
166 schema:familyName Murano
167 schema:givenName Takeshi
168 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01215532117.70
169 rdf:type schema:Person
170 sg:person.01337610735.59 schema:affiliation https://www.grid.ac/institutes/grid.272242.3
171 schema:familyName Kakizoe
172 schema:givenName Tadao
173 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01337610735.59
174 rdf:type schema:Person
175 sg:person.0645165315.21 schema:affiliation https://www.grid.ac/institutes/grid.272242.3
176 schema:familyName Kanou
177 schema:givenName Daisuke
178 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0645165315.21
179 rdf:type schema:Person
180 sg:person.0704464201.36 schema:affiliation https://www.grid.ac/institutes/grid.272242.3
181 schema:familyName Daisaki
182 schema:givenName Hiromitsu
183 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0704464201.36
184 rdf:type schema:Person
185 sg:person.0713300515.45 schema:affiliation https://www.grid.ac/institutes/grid.272242.3
186 schema:familyName Shoda
187 schema:givenName Hiroko
188 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0713300515.45
189 rdf:type schema:Person
190 sg:person.0766725261.48 schema:affiliation https://www.grid.ac/institutes/grid.272242.3
191 schema:familyName Terauchi
192 schema:givenName Takashi
193 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0766725261.48
194 rdf:type schema:Person
195 sg:pub.10.1007/bf01249629 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016456637
196 https://doi.org/10.1007/bf01249629
197 rdf:type schema:CreativeWork
198 sg:pub.10.1007/bf02984601 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050431834
199 https://doi.org/10.1007/bf02984601
200 rdf:type schema:CreativeWork
201 sg:pub.10.1007/bf03034001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018059579
202 https://doi.org/10.1007/bf03034001
203 rdf:type schema:CreativeWork
204 sg:pub.10.1007/bf03164996 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039404426
205 https://doi.org/10.1007/bf03164996
206 rdf:type schema:CreativeWork
207 sg:pub.10.1007/s12149-007-0061-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036979330
208 https://doi.org/10.1007/s12149-007-0061-8
209 rdf:type schema:CreativeWork
210 sg:pub.10.1054/bjoc.2000.1496 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008190941
211 https://doi.org/10.1054/bjoc.2000.1496
212 rdf:type schema:CreativeWork
213 https://app.dimensions.ai/details/publication/pub.1074508177 schema:CreativeWork
214 https://app.dimensions.ai/details/publication/pub.1077689341 schema:CreativeWork
215 https://app.dimensions.ai/details/publication/pub.1082413673 schema:CreativeWork
216 https://app.dimensions.ai/details/publication/pub.1083278017 schema:CreativeWork
217 https://doi.org/10.1001/jama.285.7.914 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047716064
218 rdf:type schema:CreativeWork
219 https://doi.org/10.1002/(sici)1097-0142(19970215)79:4<695::aid-cncr6>3.0.co;2-d schema:sameAs https://app.dimensions.ai/details/publication/pub.1002320901
220 rdf:type schema:CreativeWork
221 https://doi.org/10.1002/(sici)1097-0142(19980601)82:11<2227::aid-cncr18>3.0.co;2-w schema:sameAs https://app.dimensions.ai/details/publication/pub.1039814517
222 rdf:type schema:CreativeWork
223 https://doi.org/10.1016/0959-8049(95)00421-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029421313
224 rdf:type schema:CreativeWork
225 https://doi.org/10.1016/s0001-2998(96)80006-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046867727
226 rdf:type schema:CreativeWork
227 https://doi.org/10.1016/s0749-3797(01)00261-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041656773
228 rdf:type schema:CreativeWork
229 https://doi.org/10.1046/j.1442-2042.2002.00416.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1043008165
230 rdf:type schema:CreativeWork
231 https://doi.org/10.1055/s-2000-9875 schema:sameAs https://app.dimensions.ai/details/publication/pub.1057405567
232 rdf:type schema:CreativeWork
233 https://doi.org/10.1093/jjco/hyl022 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052475020
234 rdf:type schema:CreativeWork
235 https://doi.org/10.1210/jc.2003-030465 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064286866
236 rdf:type schema:CreativeWork
237 https://www.grid.ac/institutes/grid.272242.3 schema:alternateName National Cancer Centre
238 schema:name National Cancer Center, Tokyo, Japan
239 Research Center for Cancer Prevention and Screening, National Cancer Center, Tokyo, Japan
240 Screening Assessment and Management Division, Research Center for Cancer Prevention and Screening, National Cancer Center, Tokyo, Japan
241 Screening Technology and Development Division, Research Center for Cancer Prevention and Screening, National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, 104-0045, Tokyo, Japan
242 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...